Famotidine tested against COVID-19

Famotidine tested against COVID-19

Famotidine is being tested in a clinical trial for efficacy against COVID-19 based on review of early experiences of recovery in patients with heartburn put on famotidine compared to others as well as a high throughput screening for activity on the coronavirus's papainlike protease enzyme.

The report appeared in the Science Magazine.


Share Tweet Send
0 Comments
Loading...
You've successfully subscribed to COVID-19
Great! Next, complete checkout for full access to COVID-19
Welcome back! You've successfully signed in
Success! Your account is fully activated, you now have access to all content.